Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ISP Chemicals, a subsidiary of Ashland, is a prominent manufacturer of specialty chemicals and high-performance ingredients for the pharmaceutical, personal care, and industrial sectors. The company is widely recognized in the life sciences industry for its extensive portfolio of pharmaceutical excipients, including povidone-based binders and crospovidone disintegrants sold under the Plasdone and Polyplasdone brands. These materials are critical for enhancing the solubility, stability, and delivery of various drug formulations. Since its acquisition by Ashland in 2011, ISP's capabilities have been integrated into Ashland's Life Sciences business unit, focusing on advanced polymer science and formulation solutions. The company maintains significant manufacturing operations, notably in Calvert City, Kentucky, to support global pharmaceutical supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ISP Chemicals.